Certara

CERT · NASDAQ

$9.79+$0.335 (+3.54%)TodayMarket closed · Oct 20, 7:38 PM ET

Prev close $9.45

Latest news

Press releaseSep 3, 2:10 PM ETGlobe Newswire
The Market Just Told You Which Layer Of AI Biology It Is Paying For
NewsAug 4, 9:42 AM ET
Transcript: Certara Q2 2026 Earnings Conference Call
NewsAug 4, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsAug 4, 7:06 AM ET
Certara Q2 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $93.271M Miss $98.392M Estimate
Press releaseAug 4, 7:00 AM ETGlobe Newswire
Certara Reports Second Quarter 2026 Financial Results
Press releaseJul 23, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Press releaseJul 23, 9:05 AM ETPRNewswire
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers
Press releaseJul 15, 4:15 PM ETGlobe Newswire
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
Press releaseJul 14, 6:26 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
NewsJul 12, 7:31 AM ETLekha Gupta
Consumer Tech News (July 6-10): Micron Plans $250B US Expansion, Apple Signs $30B Broadcom Deal & More
Press releaseJul 9, 5:39 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Press releaseJul 7, 5:47 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
NewsJul 7, 2:18 PM ETVandana Singh
Certara, Silo Pharma Advance AI Agent Strategies with Nvidia Initiatives
NewsJul 7, 8:03 AM ET
Certara Partners With NVIDIA To Advance Its Open Integrated AI Platform, Unifying Scientific Software, Regulatory Expertise, And Proprietary Datasets With AI-First, Agentic Frameworks
Press releaseJul 6, 8:55 AM ETPRNewswire
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
Press releaseJul 6, 8:45 AM ETPRNewswire
The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel
Press releaseJun 30, 5:01 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Press releaseJun 25, 7:31 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Press releaseJun 19, 2:11 PM ETGlobe Newswire
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm
Press releaseJun 18, 7:15 PM ETGlobe Newswire
Certara, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Press releaseJun 17, 4:30 PM ETGlobe Newswire
Certara Announces CFO Transition
Press releaseJun 16, 8:45 AM ETPRNewswire
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
Press releaseJun 8, 12:02 PM ETPRNewswire
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm
Press releaseJun 4, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Press releaseMay 26, 4:54 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Press releaseMay 24, 2:14 PM ETGlobe Newswire
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm
Press releaseMay 21, 6:40 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Press releaseMay 20, 6:00 PM ETBusiness Wire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Press releaseMay 18, 7:00 PM ETGlobe Newswire
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Press releaseMay 15, 11:15 AM ETGlobe Newswire
CERTARA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm
Press releaseMay 13, 6:00 PM ETBusiness Wire
CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
Press releaseMay 12, 12:15 PM ETGlobe Newswire
Certara, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
NewsMay 11, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsMay 11, 12:51 PM ETPiero Cingari
S&P 500 Tops 7,400 As Copper Hits Record Highs: Stock Market Today
NewsMay 11, 8:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseMay 7, 8:00 AM ETBusiness Wire
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
NewsApr 22, 3:23 PM ETVandana Singh
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

The Market Just Told You Which Layer Of AI Biology It Is Paying For

Transcript: Certara Q2 2026 Earnings Conference Call

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Certara Q2 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $93.271M Miss $98.392M Estimate

Certara Reports Second Quarter 2026 Financial Results

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

Consumer Tech News (July 6-10): Micron Plans $250B US Expansion, Apple Signs $30B Broadcom Deal & More

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

Certara, Silo Pharma Advance AI Agent Strategies with Nvidia Initiatives

Certara Partners With NVIDIA To Advance Its Open Integrated AI Platform, Unifying Scientific Software, Regulatory Expertise, And Proprietary Datasets With AI-First, Agentic Frameworks

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models

The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm

Certara, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Certara Announces CFO Transition

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It

CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

CERTARA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm

CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

Certara, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

12 Health Care Stocks Moving In Monday's Intraday Session

S&P 500 Tops 7,400 As Copper Hits Record Highs: Stock Market Today

12 Health Care Stocks Moving In Monday's Pre-Market Session

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

Certara Strategic Business Divestiture Comes At Right Time, Says Analyst